-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Organogenesis Holdings Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
- Organogenesis Holdings Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $2.5M, a 35.2% decline year-over-year.
- Organogenesis Holdings Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $3.5M, a 21.7% decline year-over-year.
- Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2023 was $5.45M, a 14.7% increase from 2022.
- Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2022 was $4.75M.
- Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2021 was -$31.1M, a 5971% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)